Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply

Brad H Rovin1, Dan Birmingham1, Rodrigo Cartin-Ceba2

  • 1Ohio State University Wexner Medical Center, Columbus, OH.

Arthritis & Rheumatology (Hoboken, N.J.)
|April 8, 2017
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Grade Proteinuria in Lupus Nephritis: Why "Mild" Is Often Misleading.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Insights from the BLISS-LN Phase 3 study of biomarker associations with kidney response to belimumab in lupus nephritis.

Kidney international·2026
Same author

Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney international·2026
Same author

Authors' Reply: Convergent Proteinuria Reduction across Distinct Therapeutic Pathways in IgA Nephropathy.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Complement inhibitors and B cell-modifying agents for IgA nephropathy-a Kidney Disease: Improving Global Outcomes (KDIGO) commentary.

Kidney international·2026
Same author

A Pooled Analysis of Sex Differences in Lupus Nephritis.

Kidney international reports·2026
Same journal

Same Family, Different Stories: Distinct Peripheral Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same journal

ACR Treatment Guidelines and Expert Opinion: The Continuum of Knowledge Guiding Clinical Decision-Making.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same journal

DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) mutations limit normal and autoreactive CD4+ T follicular helper responses and attenuate T cell-driven joint inflammation.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same journal

Treatment of Patients with CPPD Disease: Where Do We Begin and Where Are We Going?

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same journal

Efficacy and Safety of Nanoencapsulated Sirolimus plus Pegadricase: Results from the Randomized, Placebo-Controlled Phase 3 Trials.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same journal

Fibroblast Mitochondrial Ca2+ Overload Drives Skin Fibrosis via mtDNA Leakage and cGAS-STING Activation in Systemic Sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
See all related articles